305 related articles for article (PubMed ID: 11713615)
21. Morphine attenuates the expression of sensitization to ethanol, but opioid antagonists do not.
Abrahao KP; Quadros IM; Souza-Formigoni ML
Neuroscience; 2008 Oct; 156(4):857-64. PubMed ID: 18804151
[TBL] [Abstract][Full Text] [Related]
22. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
[TBL] [Abstract][Full Text] [Related]
23. Changes in opioid and cannabinoid receptor protein following short-term combination treatment with delta(9)-tetrahydrocannabinol and morphine.
Cichewicz DL; Haller VL; Welch SP
J Pharmacol Exp Ther; 2001 Apr; 297(1):121-7. PubMed ID: 11259535
[TBL] [Abstract][Full Text] [Related]
24. Comparative effects of pulmonary and parenteral Δ⁹-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats.
Manwell LA; Mallet PE
Psychopharmacology (Berl); 2015 May; 232(9):1655-65. PubMed ID: 25395060
[TBL] [Abstract][Full Text] [Related]
25. Antinociception and sedation following intracerebroventricular administration of Δ⁹-tetrahydrocannabinol in female vs. male rats.
Wakley AA; Craft RM
Behav Brain Res; 2011 Jan; 216(1):200-6. PubMed ID: 20692296
[TBL] [Abstract][Full Text] [Related]
26. Exposure to delta-9-tetrahydrocannabinol (THC) increases subsequent heroin taking but not heroin's reinforcing efficacy: a self-administration study in rats.
Solinas M; Panlilio LV; Goldberg SR
Neuropsychopharmacology; 2004 Jul; 29(7):1301-11. PubMed ID: 15039767
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic factors in sex differences in Delta 9-tetrahydrocannabinol-induced behavioral effects in rats.
Tseng AH; Harding JW; Craft RM
Behav Brain Res; 2004 Sep; 154(1):77-83. PubMed ID: 15302113
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the discriminative stimulus properties of delta 9-tetrahydrocannabinol and CP 55,940 in rats and rhesus monkeys.
Gold LH; Balster RL; Barrett RL; Britt DT; Martin BR
J Pharmacol Exp Ther; 1992 Aug; 262(2):479-86. PubMed ID: 1323651
[TBL] [Abstract][Full Text] [Related]
29. Enhanced morphine-induced ethanol drinking in alcohol-preferring alko alcohol rats sensitized to morphine.
Ojanen SP; Hyytiä P; Kiianmaa K
Alcohol Clin Exp Res; 2006 Apr; 30(4):621-9. PubMed ID: 16573579
[TBL] [Abstract][Full Text] [Related]
30. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
Solinas M; Goldberg SR
Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
[TBL] [Abstract][Full Text] [Related]
31. Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells.
Heyser CJ; Hampson RE; Deadwyler SA
J Pharmacol Exp Ther; 1993 Jan; 264(1):294-307. PubMed ID: 8380864
[TBL] [Abstract][Full Text] [Related]
32. Repeated pre-exposure to morphine into the ventral pallidum enhances morphine-induced place preference: involvement of dopaminergic and opioidergic mechanisms.
Zarrindast MR; Ebrahimi-Ghiri M; Rostami P; Rezayof A
Behav Brain Res; 2007 Jul; 181(1):35-41. PubMed ID: 17451818
[TBL] [Abstract][Full Text] [Related]
33. Effects of systemic and intraventricular administration of cannabinoids on schedule-controlled responding in the squirrel monkey.
Carney JM; Balster RL; Martin BR; Harris LS
J Pharmacol Exp Ther; 1979 Sep; 210(3):399-404. PubMed ID: 113528
[TBL] [Abstract][Full Text] [Related]
34. AMPA antagonist LY293558 blocks the development, without blocking the expression, of behavioral sensitization to morphine.
Carlezon WA; Rasmussen K; Nestler EJ
Synapse; 1999 Mar; 31(4):256-62. PubMed ID: 10051106
[TBL] [Abstract][Full Text] [Related]
35. Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.
Lemberger L; Martz R; Rodda B; Forney R; Rowe H
J Clin Invest; 1973 Oct; 52(10):2411-7. PubMed ID: 4729039
[TBL] [Abstract][Full Text] [Related]
36. The effect of morphine sensitization on extracellular concentrations of GABA in dorsal hippocampus of male rats.
Farahmandfar M; Zarrindast MR; Kadivar M; Karimian SM; Naghdi N
Eur J Pharmacol; 2011 Nov; 669(1-3):66-70. PubMed ID: 21872582
[TBL] [Abstract][Full Text] [Related]
37. Dopaminergic system does not play a major role in the precipitated cannabinoid withdrawal syndrome.
Sañudo-Peña MC; Force M; Tsou K; McLemore G; Roberts L; Walker JM
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1121-4. PubMed ID: 11216447
[TBL] [Abstract][Full Text] [Related]
38. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part I: development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology studies in rodents.
Manwell LA; Charchoglyan A; Brewer D; Matthews BA; Heipel H; Mallet PE
J Pharmacol Toxicol Methods; 2014; 70(1):120-7. PubMed ID: 24973534
[TBL] [Abstract][Full Text] [Related]
39. No antinociceptive synergy between morphine and delta-9-tetrahydrocannabinol in male and female rats with persistent inflammatory pain.
Britch SC; Craft RM
Behav Pharmacol; 2021 Dec; 32(8):630-639. PubMed ID: 34561365
[TBL] [Abstract][Full Text] [Related]
40. Morphine sensitization increases the extracellular level of glutamate in CA1 of rat hippocampus via μ-opioid receptor.
Farahmandfar M; Karimian SM; Zarrindast MR; Kadivar M; Afrouzi H; Naghdi N
Neurosci Lett; 2011 Apr; 494(2):130-4. PubMed ID: 21382441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
